简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-07-05 14:26 Korean Cosmetic Brand PETITCOMO Launches Bling Bling Light Up Masks for Summer Skin Treatment
2019-07-04 09:59 Takeda to Demonstrate Global Leadership in Hematology at ISTH 2019
2019-07-04 09:50 Ping An Shares Insights on the Transformative Power of Technology for Finance & Healthcare at “Summer Davos”
2019-07-03 13:47 Octapharma to Present New Data on Management of People with Haemophilia A or von Willebrand Disease at ISTH 2019
2019-07-02 09:33 Takeda Completes Sale of Xiidra® to Novartis
2019-07-02 09:30 Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation
2019-07-01 18:38 Terns Pharmaceuticals Appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer
2019-07-01 11:28 Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program, Supporting Disease Prevention to Improve Health in Developing and Emerging Countries
2019-06-28 15:34 U.S. Food and Drug Administration Supports Principles of Open Sharing of Data
2019-06-26 18:10 Patient Safety Movement Foundation Announces First Curriculum Commitments
2019-06-25 16:45 Terns Pharmaceuticals Announces Exclusive Licensing and Collaboration Agreement with GENFIT to Develop and Commercialize Elafibranor in the Greater China Region
2019-06-25 16:22 L’Oréal Rewards Social Initiatives Led by Dermatologists at World Congress of Dermatology in Milan
2019-06-25 15:00 SpeeDx announce a collaborative agreement with GSK to supply tests and technology
2019-06-25 09:37 Ferring Collaboration with Digital Health Innovators WOOM Aims to Help More People Build Families Faster
2019-06-24 10:42 Seven and Eight Biopharmaceuticals Inc. Announces Clinical Collaboration
2019-06-21 11:42 Robot Destroys Hospital Bugs - IERA Award 2019 by IEEE and IFR
2019-06-20 13:09 Japan’s MHLW Approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for Treatment of Relapsed/Refractory FLT3-ITD AML. Expands Use to Include Specimens Collected in EDTA
2019-06-20 11:44 Children’s Hospital Los Angeles Ranked No. 1 Children’s Hospital in the Western U.S., Rises to No. 5 Overall
2019-06-20 09:40 Blossom Innovations Advances Its Latest Medical Technology Platform for Dermatology
2019-06-18 09:41 Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors

Business Wire Weibo

Press Releases

Latest Releases